VitaNova Life Sciences (VNOV) Gross Profit (2017 - 2026)

VitaNova Life Sciences (VNOV) has 4 years of Gross Profit data on file, last reported at $264662.0 in Q2 2026.

• Quarterly Gross Profit fell 77.13% year-over-year to $264662.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $910589.0 (down 42.21% YoY) and the FY2026 annual result came in at $910589.0, down 42.21% from the prior year.
• Gross Profit fell to $264662.0 in Q2 2026, from $316343.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $1.2 million in Q2 2025 to a low of $26100.0 in Q1 2024.
• A 3-year average of $286401.0 and a median of $225057.5 in 2025 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2025 — Gross Profit soared 625.33% — and 2026, when it sank 77.13%.
• Tracing VNOV's Gross Profit over 3 years: stood at $155834.0 in 2024, then jumped by 67.36% to $260803.0 in 2025, then increased by 1.48% to $264662.0 in 2026.
• The last three Gross Profit figures came in at $264662.0 (Q2 2026), $316343.0 (Q1 2026), and $260803.0 (Q4 2025), per Business Quant data.